Profile
David Sherris is the founder.
He founded Paloma Pharmaceuticals, Inc. in 2005 and holds the title of President, CEO, Treasurer & Director.
Currently, Dr. Sherris is the Chairman, President & Chief Executive Officer at Attivare Therapeutics, Inc. since 2024.
In the past, he served as the Chief Scientific Officer at RestorGenex Corp.
from 2015 to 2016.
He also held the position of President at VasculoMedics, Inc. Dr. Sherris obtained a doctorate degree from the University of Utah.
David Sherris active positions
| Companies | Position | Start |
|---|---|---|
Paloma Pharmaceuticals, Inc.
Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs and related products | Founder | 01/01/2005 |
Attivare Therapeutics, Inc.
Attivare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biomaterial vaccines | Chief Executive Officer | 11/11/2024 |
Former positions of David Sherris
| Companies | Position | End |
|---|---|---|
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and sells medicines | Chief Tech/Sci/R&D Officer | 08/01/2016 |
VasculoMedics, Inc.
VasculoMedics, Inc. BiotechnologyHealth Technology Produces and develops zinc finger transcription factors for medical use | President | - |
Training of David Sherris
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Paloma Pharmaceuticals, Inc.
Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs and related products | Health Technology |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and sells medicines | Health Technology |
VasculoMedics, Inc.
VasculoMedics, Inc. BiotechnologyHealth Technology Produces and develops zinc finger transcription factors for medical use | Health Technology |
Attivare Therapeutics, Inc.
Attivare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biomaterial vaccines | Commercial Services |
- Stock Market
- Insiders
- David Sherris
















